+91 -77679 22244   [email protected]

Grapitail

Novel drug for osteoarthritic pain
FDA approved in 2016 for Dogs
A non-COX inhibiting NSAID that specifically blocks the EP4 receptor, the primary mediator of canine OA pain and inflammation
Use for All Stages of OA
Lower side effects- Safe to use Daily
Reduces impact GI, Kidney and liver homeostasis
For the control of pain and inflammation associated with osteoarthritis in dogs
Grapitail

Dosage & Directions

2 mg/kg once daily
It should be given empty stomach (e.g., in the morning) and at least one hour before the next meal, once daily at a target dose of 2 mg per kg body weight
For use in Dogs only

Presentation

10 x 1 x 6 tablets